SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

Escalating Middle East tensions, particularly threats to the Strait of Hormuz and reports of tanker attacks, are fueling a sharp rise in USO as the community debates whether crude prices will sustain a significant surge or see a rapid pullback due to US interventions to stabilize energy flow.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is trending after exceeding earnings expectations and providing a highly bullish outlook driven by its key role in AI data center custom silicon and optical interconnect solutions. The strong report is fueling optimism among investors and analysts, who are raising price targets and discussing the company's significant growth potential within the expanding AI infrastructure landscape.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending amid escalating Middle East tensions driving up oil prices and inflation concerns, as the market also braces for the crucial Non-Farm Payrolls report. Community sentiment is sharply divided, with 'buy the dip' calls countering warnings of a broader market downturn due to these persistent geopolitical and macroeconomic headwinds.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending amid escalating geopolitical tensions involving the US and Iran, with many in the community viewing the conflict as a costly distraction from domestic issues and the controversial release of Epstein files. This is compounded by community discussions around rising oil prices and a significant shake-up in the administration following the firing of DHS Secretary Kristi Noem.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

INDO is trending as crude oil prices climb significantly due to escalating geopolitical tensions and supply concerns, fueling community discussion around its small float and high short interest, with many anticipating a substantial rally akin to its past performance if oil continues its ascent.

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Berkeley Heights, NJ.

Tonix Pharmaceuticals Holding Corp

Tonix Pharmaceuticals is trending after its uplisting to the Nasdaq Global Select Market and securing crucial formulary coverage for its new fibromyalgia drug, Tonmya, with major insurers including UnitedHealthcare and Kaiser. While many are optimistic about accelerating sales and growing institutional interest, the community remains divided, with some fearing continued dilution amidst the company's cash burn.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena is trending as its latest earnings, despite an EPS miss, delivered a revenue beat and a bullish long-term outlook, driven by accelerating AI and cloud demand for high-speed optical networking. The community is focused on its role as a critical AI infrastructure play, with analysts raising price targets on its significant backlog and technological leadership.

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in South San Francisco, CA.

Omada Health Inc.

Omada Health, Inc.

Omada Health is trending following strong Q4 earnings that significantly beat expectations and positive forward guidance, leading Morgan Stanley to reiterate a "Buy" rating and suggest the stock is undervalued. The community is actively discussing its upside potential given its performance in the digital health sector, especially within GLP-1 medication support.

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA.

Erasca Inc

Erasca is trending amid a new clinical collaboration evaluating its pan-RAS molecular glue and recent patent issuance for its pan-KRAS inhibitor, driving community discussions comparing its pipeline to industry leaders and highlighting its potential in RAS-driven cancer therapies.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is trending due to escalating Middle East tensions pushing oil prices higher and intensifying concerns over inflation and potential rate hikes. The community remains divided, with many expressing fears of a significant downturn, while others note the market's consistent "V" shaped recoveries, fueled by perceptions of algorithmic propping.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 30,941 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 30,941 shares of the business's stock in a transaction on Tuesday, March 3rd. The shares were sold at an...

Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells $495,056.00 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) COO Julie Rubinstein sold 30,941 shares of the stock in a transaction on Thursday, March 5th. The shares were sold at an average...

ARK Investment Management LLC Has $47.36 Million Stake in Adaptive Biotechnologies Corporation $ADPT

ARK Investment Management LLC trimmed its position in shares of Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 21.2% during the 3rd quarter, according to its most recent Form 13F...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 10,000 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was sold at an...

Harlan Robins Sells 14,233 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 14,233 shares of the stock in a transaction on Tuesday, March 3rd. The shares were sold at an average...

Chad Robins Sells 53,083 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 53,083 shares of Adaptive Biotechnologies stock in a transaction on Tuesday, March 3rd. The stock was sold at...

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $823,848.16 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 53,083 shares of the business's stock in a transaction that occurred on Tuesday, March 3rd. The stock was...

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Sells $2,924,427.09 in Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 182,891 shares of the company's stock in a transaction dated Friday, February 27th. The shares were sold at...

Chad Robins Sells 289,024 Shares of Adaptive Biotechnologies (NASDAQ:ADPT) Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) CEO Chad Robins sold 289,024 shares of the stock in a transaction on Monday, March 2nd. The shares were sold at an average price...

Adaptive Biotechnologies CEO Flags MRD Momentum, Lifts 2025 Volume Outlook to 30%+ at TD Cowen Conf.

Adaptive Biotechnologies (NASDAQ:ADPT) CEO Chad Robins told investors at the 46th Annual TD Cowen Healthcare Conference that the company is looking to build on what he described as strong recent...

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Current Price	$15.93
Prev Close	$16.44
Open	$16.20
Dividend Yield	0.00%
50-Day Moving Average	$16.87
Beta	1.69
Avg. Volume	1.86M
PE Ratio	-41.23

52-Week High	$20.76
52-Week Low	$6.26
Market Capitalization	$2.53B
EPS (Annual)	-$0.3922
Price to Book	11.55
Revenue Per Employee	$443,871.79

ADPT
Adaptive Biotechnologies Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADPT News

ADPTAdaptive Biotechnologies Corp